• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

Up­dat­ed: No­vo Nordisk sees growth slow­ing this year, plans Ca­griSe­ma fil­ing for 2026

4 months ago
Pharma
Manufacturing

Am­gen an­nounces hold on Phase 1 obe­si­ty can­di­date, pipeline cuts

4 months ago
R&D
Pharma

J&J asks court for quick de­ci­sion in 340B re­bate mod­el fight

4 months ago
Pharma
Law

Af­ter re­launch, Roche gets FDA ap­proval for oc­u­lar im­plant in di­a­bet­ic mac­u­lar ede­ma

4 months ago
R&D
FDA+

Pfiz­er says it has at least $10B avail­able for deals in 2025, with a fo­cus on pipeline

4 months ago
Deals
Pharma

Mer­ck CEO says he’s con­fi­dent in growth de­spite Gar­dasil ‘head­wind’

4 months ago
China
Pharma

We’re about to find out which RFK Jr. will show up at HHS

4 months ago
Editor's note

Il­lu­mi­na added to Chi­na's black­list fol­low­ing Biose­cure Act, tar­iffs

4 months ago
China
Pharma

Turn­stone stops TIL stud­ies; GH Re­search’s $150M of­fer­ing

4 months ago
News Briefing

Up­dat­ed: RFK Jr. ad­vances out of Sen­ate com­mit­tee with Cas­sidy’s sup­port

4 months ago
People
FDA+

FDA ap­proves Su­per­nus’ Parkin­son’s drug-de­vice af­ter two re­jec­tions

4 months ago
Pharma
FDA+

How opi­oid ad­dic­tion treat­ment start­up Bi­cy­cle Health reached a prof­it

4 months ago
Startups
Health Tech

New study will try to stop Alzheimer’s decades be­fore it be­gins, us­ing ex­per­i­men­tal Eli Lil­ly drug

4 months ago
R&D

Bavar­i­an Nordic’s stock sinks af­ter 2024 rev­enues un­der­whelm

4 months ago
Pharma
Manufacturing

Up­dat­ed: Pfiz­er sticks to 2025 pro­jec­tions as Covid sales sta­bi­lize, R&D re­vamp con­tin­ues

4 months ago
Pharma

Re­gen­eron will start de­liv­er­ing quar­ter­ly div­i­dends 37 years in­to its ex­is­tence

4 months ago
Pharma

Astel­las shakes up man­age­ment de­spite im­pres­sive nine-month earn­ings

4 months ago
People
Pharma

Up­dat­ed: Mer­ck tem­porar­i­ly paus­es Gar­dasil ship­ments to Chi­na fol­low­ing sales slow­down

4 months ago
China
Pharma

Flag­ship spin­out Omega is days away from bank­rupt­cy, fil­ing shows

4 months ago
People
Startups

Gene-edit­ed pig kid­neys to be test­ed in more hu­mans soon, two com­pa­nies say

4 months ago
R&D

US biosim­i­lar 'void' spells trou­ble as bi­o­log­ic patent ex­pi­ra­tions loom, IQVIA re­port says

4 months ago
Pharma

Ex­clu­sive: Noom cuts coach­es and cus­tomer ser­vice staff as few­er sign up

4 months ago
People
Health Tech

Bio­gen’s re­vised re­search strat­e­gy is to avoid be­com­ing ob­so­lete, top ex­ec says

4 months ago
Deals
R&D

Charles Riv­er to shut down North Car­oli­na pathol­o­gy fa­cil­i­ty, says it's not a 's­trate­gic fit'

4 months ago
People
Outsourcing
First page Previous page 46474849505152 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times